Cargando…

Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)

BACKGROUND: Chronic treatment of hypertension or heart failure very often includes an angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) as renin-angiotensin system inhibitors (RASi) treatments. To stop or not to stop these medications before major surgery rema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Legrand, Matthieu, Futier, Emmanuel, Leone, Marc, Deniau, Benjamin, Mebazaa, Alexandre, Plaud, Benoît, Coriat, Pierre, Rossignol, Patrick, Vicaut, Eric, Gayat, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402139/ https://www.ncbi.nlm.nih.gov/pubmed/30836981 http://dx.doi.org/10.1186/s13063-019-3247-1

Ejemplares similares

Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19
por: Dudoignon, Emmanuel, et al.
Publicado: (2020)

‘Chronomics’ in ICU: circadian aspects of immune response and therapeutic perspectives in the critically ill
por: Papaioannou, Vasilios, et al.
Publicado: (2014)

The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial
por: Legrand, Matthieu, et al.
Publicado: (2020)

The Yin and Yang of the Renin–Angiotensin–Aldosterone System in Acute Kidney Injury
por: Legrand, Matthieu, et al.
Publicado: (2021)

A case series of life-threatening succinylcholine-induced anaphylaxis
por: Le Dorze, Matthieu, et al.
Publicado: (2017)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
por: Garcia, Bruno, et al.
Publicado: (2023)

Back-to-back comparison of penKID with NephroCheck® to predict acute kidney injury at admission in intensive care unit: a brief report
por: Gayat, Etienne, et al.
Publicado: (2018)

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
por: Bobkova, Irina, et al.
Publicado: (2020)

Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial
por: Rathkolb, Vincent, et al.
Publicado: (2023)

Alteration of the Renin–Angiotensin–Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
por: Picod, Adrien, et al.
Publicado: (2021)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
por: Darden, Douglas, et al.
Publicado: (2019)

Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes
por: Pavlidis, George, et al.
Publicado: (2021)

Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
por: An, Jaejin, et al.
Publicado: (2023)

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
por: Cohen, Jordana B, et al.
Publicado: (2021)

Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study
por: Mebazaa, Alexandre, et al.
Publicado: (2015)

Renin-Angiotensin System Inhibitors in Advanced CKD: a #NephJC Editorial on STOP-ACEi
por: Thanabalasingam, Susan, et al.
Publicado: (2023)

Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis
por: Kerneis, Mathieu, et al.
Publicado: (2020)

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial
por: Takagi, Koji, et al.
Publicado: (2021)

Predictive Performance of Neutrophil Gelatinase Associated Lipocalin, Liver Type Fatty Acid Binding Protein, and Cystatin C for Acute Kidney Injury and Mortality in Severely Ill Patients
por: Asakage, Ayu, et al.
Publicado: (2024)

Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial
por: Vissers, Frans H. J. A., et al.
Publicado: (2007)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
por: Bauer, Axel, et al.
Publicado: (2021)

Effect of Discontinuation of Renin Angiotensin-System Inhibitors in Patients With Advanced Chronic Kidney Disease: A Meta-Analysis
por: Naveed, Husnain, et al.
Publicado: (2023)

Outcomes of discontinuing renin-angiotensin system inhibitors: a study protocol for conducting systematic review and meta-analysis
por: Suzuki, Taihei, et al.
Publicado: (2023)

The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
por: Lumbers, Eugenie R., et al.
Publicado: (2020)

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study
por: van Lier, Dirk, et al.
Publicado: (2023)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis
por: Tang, Chen, et al.
Publicado: (2023)

Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial
por: Kliim-Hansen, Vivian, et al.
Publicado: (2022)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial
por: Butler, Javed, et al.
Publicado: (2021)

The renin–angiotensin system and diabetes: An update
por: Ribeiro-Oliveira, Antônio, et al.
Publicado: (2008)

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN
por: Fischer-Ferraro, Catalina, et al.
Publicado: (1971)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Within the Brain: The Renin Angiotensin System
por: Jackson, LaDonya, et al.
Publicado: (2018)

Renin-Angiotensin System and Cardiovascular Functions
por: Wu, Chia-Hua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m3o1hhd6me3ush022549l268if